Milković, Lidija; Mlinarić, Monika; Lučić, Ivan; Čipak Gašparović, Ana (2023) The Involvement of Peroxiporins and Antioxidant Transcription Factors in Breast Cancer Therapy Resistance. Cancers, 15 (24). ISSN 2072-6694
![[img]](http://fulir.irb.hr/style/images/fileicons/application_pdf.png) |
PDF
- Published Version
- article
Available under License Creative Commons Attribution. Download (1MB) |
Abstract
Breast cancer is still the leading cause of death in women of all ages. The reason for this is therapy resistance, which leads to the progression of the disease and the formation of metastases. Multidrug resistance (MDR) is a multifactorial process that leads to therapy failure. MDR involves multiple processes and many signaling pathways that support each other, making it difficult to overcome once established. Here, we discuss cellular-oxidative-stress-modulating factors focusing on transcription factors NRF2, FOXO family, and peroxiporins, as well as their possible contribution to MDR. This is significant because oxidative stress is a consequence of radiotherapy, chemotherapy, and immunotherapy, and the activation of detoxification pathways could modulate the cellular response to therapy and could support MDR. These proteins are not directly responsible for MDR, but they support the survival of cancer cells under stress conditions.
| Item Type: | Article | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Uncontrolled Keywords: | aquaporin; peroxiporin; NRF2; FOXO | ||||||||
| Subjects: | BIOMEDICINE AND HEALTHCARE > Basic Medical Sciences | ||||||||
| Divisions: | Division of Molecular Medicine | ||||||||
| Projects: |
|
||||||||
| Depositing User: | Ivana Vuglec | ||||||||
| Date Deposited: | 30 Mar 2026 12:54 | ||||||||
| URI: | http://fulir.irb.hr/id/eprint/11544 | ||||||||
| DOI: | 10.3390/cancers15245747 |
Actions (login required)
 |
View Item |
Altmetric
Altmetric
